The DOI matches its Crossref record.
Progestin regulation of cellular proliferation.
Abstract
THE control of cellular proliferation is known to involve a delicate balance between the effects of different regulatory molecules including hormones and growth factors which provide, in the immediate environment of the cell, signals to stimulate or inhibit cellular replication (1). The past decade has seen significant progress in the identification and characterization of novel regulatory molecules, generally referred to as growth factors, and definition of their molecular mechanisms of action (2, 3). With the recent emphasis on peptide growth factors it is perhaps less well appreciated that some of the largest physiological changes (both positive and negative) in rates of growth and cell proliferation are mediated by steroid hormones. Recent studies on breast cancer cells (4) and immature rat uterus (5, 6), illustrating estrogenic control of autocrine and paracrine growth factor production, support the view that some of these steroid-induced responses are intimately linked to growth factor-mediated pathways although debate continues as to whether the growth factor response is the cause, or the consequence, of the estrogenic effect on cellular proliferation (7, 8). Generally speaking, the molecular mechanisms by which steroid hormones control proliferation are not well defined, with the most developed knowledge being in the area of estrogen action where a number of recent reviews are available (4, 9–11).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“recent data suggest that progestins exert a negative impact on breast cancer (2-5), with recent reports indicating an increased risk of the disease in women (6,7).”
Citations
Cited by
Sorted by citations
Items 201–300 of 660
Pu, H., Wen, X., Luo, D., & Guo, Z. (2022) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2022.106199 · Cited by 54
Expression and Hormonal Regulation of the Sox4 Gene in Mouse Female Reproductive Tissues1
Hunt, S. M. N., & Clarke, C. L. (1999) · Biology of Reproduction · doi:10.1095/biolreprod61.2.476 · Cited by 52
Self-citationSteroid receptors in human breast tumorigenesis and breast cancer progression.
Murphy, L., & Watson, P. (2002) · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · doi:10.1016/s0753-3322(01)00157-3 · Cited by 59
Musgrove, E. A., Hui, R., Sweeney, K. J. E., Watts, C. K. W., & Sutherland, R. L. (1996) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/bf02013639 · Cited by 53
Self-citationEden, J. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.201 · Cited by 52
A cohort study of hormone replacement therapy given to women previously treated for breast cancer
Dew, J. E., Eden, J., Beller, E., Magarey, C. J., Schwartz, P. E., Crea, P., & Wren, B. G. (1998) · Climacteric · doi:10.3109/13697139809085529 · Cited by 52
Moffatt-Blue, C. S., Sury, J. J., & Young, K. A. (2006) · Reproduction · doi:10.1530/rep.1.00870 · Cited by 51
“It is well known that the uterus is a major target of estradiol and that estradiol is essential in maintaining uterine function (Clarke & Sutherland 1990).”
Sartorius, C., Takimoto, G. S., Richer, J., Tung, L. W., & Horwitz, K. B. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0240165 · Cited by 51
Progestin upregulates G‐protein‐coupled receptor 30 in breast cancer cells
Ahola, T. M., Purmonen, S., Pennanen, P. T., Zhuang, Y., Tuohimaa, P., & Ylikomi, T. J. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.02912.x · Cited by 51
Progesterone receptor variants found in breast cells repress transcription by wild-type receptors
Richer, J. K., Lange, C. A., Wierman, A., Brooks, K. M., Tung, L. W., Takimoto, G. S., & Horwitz, K. B. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1005941117247 · Cited by 50
“On the other hand, in the breast, the same concentrations of progestins are not antiproliferative, and therefore are not protective [1, 2, 44].”
BackgroundTiwari, D., Bose, P. D., Das, S., et al. (2015) · Meta Gene · doi:10.1016/j.mgene.2014.12.002 · Cited by 50
“…by stimulating and regulating various functions like implantation of the embryo, promoting uterine growth and suppressing myometrical contractility (Clarke and Sutherland, 1990; Graham and Clarke, 1997; Pepe and Albrecht, 1995) and also acting as an antiinflammatory agent and regulator of immune…”
BackgroundProgesterone for treatment of symptomatic menopausal women
Prior, J. C. (2018) · Climacteric · doi:10.1080/13697137.2018.1472567 · Cited by 48
Shao, R., Weijdegård, B., Ljungström, K., et al. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00582.2005 · Cited by 50
“Therefore, it is likely that both antiapoptotic (in this study) and antiproliferative effects (7, 42) are mediated by the functional PR protein expression in the fallopian tube and uterus during their development as a result of changing serum steroid levels.”
BackgroundAntagonism of androgen action in prostate tumor cells by retinoic acid
Young, C. Y. F., Murtha, P. E., Andrews, P. E., Lindzey, J. K., & Tindall, D. J. (1994) · The Prostate · doi:10.1002/pros.2990250106 · Cited by 50
Bartol, F. F., Johnson, L. L., Floyd, J. G., et al. (1995) · Theriogenology · doi:10.1016/0093-691x(95)00035-7 · Cited by 49
Ganesan, K., Balachandran, C., Manohar, B. M., & Puvanakrishnan, R. (2008) · Bone · doi:10.1016/j.bone.2008.05.025 · Cited by 49
“However, it was reported earlier that progesterone antagonized estrogen's effects in uterus by downregulation of cytoplasmic and nuclear estrogen receptor concentrations [37].”
BackgroundSumida, T., Itahana, Y., Hamakawa, H., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1155 · Cited by 49
“The sex steroid hormones, estrogen and progesterone (Pg), play an important role in normal mammary gland development, and it is believed that breast cancer progression is influenced by them and their receptors (1, 2).”
BackgroundChetrite, G. S., Pâris, J., Botella, J., et al. (1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(96)00094-5 · Cited by 49
Growth Factor Control of Cultured Rat Uterine Stromal Cell Proliferation is Progesterone Dependent1
Piva, M. A., Flieger, O., & Rider, V. (1996) · Biology of Reproduction · doi:10.1095/biolreprod55.6.1333 · Cited by 49
Apoptosis induced by progesterone in human ovarian cancer cell line SNU‐840
Yu, S. S., Lee, M., Shin, S., et al. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1171 · Cited by 48
Su, M., Lee, I.-W., Chen, Y., et al. (2010) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-010-9510-8 · Cited by 47
“Progesterone plays a crucial role in the regulation of female reproduction, including regulating the menstrual cycle, maintaining implantation, promoting uterine growth and suppressing uterine contraction [3, 4].”
Backgroundda Costa, R. P. R., Ferreira-Dias, G. M., Mateus, L. M., et al. (2006) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2006.03.007 · Cited by 47
“However, increase in uterine size and cell proliferation under the influence of E2 has been reported [49,51–53].”
BackgroundKhan, J. A., Bellance, C., Guiochon‐Mantel, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045993 · Cited by 47
“P4 exerts either growth stimulatory or inhibitory effects depending on target cells [35–39].”
BackgroundYue, L., Daikoku, T., Hou, X., et al. (2005) · Endocrinology · doi:10.1210/en.2004-1605 · Cited by 47
“Estrogen induces proliferation of uterine epithelial cell, whereas P4 as a differentiation factor counteracts estrogeninduced epithelial cell proliferation but stimulates epithelial cell differentiation in preparation for embryo implantation via steroid nuclear receptors (31).”
BackgroundArnett-Mansfield, R. L., Graham, J. D., Hanson, A. R., et al. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0041 · Cited by 47
“Our previous study, showing that PR distribution in vivo is regulated by cyclical progesterone (10), suggests that PR foci may be involved with active transcription, because they are most prominent in a phase of the menstrual cycle where serum progesterone levels are high and at a time when clearly defined morphologic…”
BackgroundSelf-citationKaneko, K. J., Gélinas, C., & Gorski, J. (1993) · Biochemistry · doi:10.1021/bi00083a039 · Cited by 47
Androgen receptor polymorphisms and endometrial cancer risk
McGrath, M., Lee, I., Hankinson, S. E., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21436 · Cited by 47
“effects of estrogen by inducing glandular and stromal differentiation.(40,41) However, the role of androgens and the androgen recep-”
BackgroundRummukainen, J. K., Salminen, T. M., Lundin, J. E., et al. (2001) · Modern Pathology · doi:10.1038/modpathol.3880431 · Cited by 47
“The expression of c-myc mRNA is rapidly but transiently induced by progestin treatment, whereas relatively long-term treatment results in suppression of its expression (32, 33).”
BackgroundBotella, J., Duranti, E., Duc, I., et al. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90170-8 · Cited by 47
Estrogen and progestin effects in human breast carcinogenesis
King, R. J. B. (1993) · Breast Cancer Research and Treatment · doi:10.1007/bf00683189 · Cited by 47
“One review [ 34 ] pointed out the problems of interpreting data from cultured breast because of cell heterogeneity and loss of receptor pathways in culture.”
BackgroundInfluentialInsulin‐like Growth Factor‐I (IGF‐I) Receptors in Breast Cancer
PEZZINO, V., Papa, V., Milazzo, G., Gliozzo, B., Russo, P., & Scalia, P. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb16236.x · Cited by 47
Zhu, B. T., Roy, D., & Liehr, J. G. (1993) · Endocrinology · doi:10.1210/endo.132.2.8381068 · Cited by 47
Prior, J. C. (2020) · Drug Discovery Today: Disease Models · doi:10.1016/j.ddmod.2020.11.005 · Cited by 47
Sex steroid receptors in human lung diseases
Verma, M. K., Miki, Y., & Sasano, H. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.07.013 · Cited by 46
Mulas, J. M. D. L., van Niel, M. H., Millán, Y., et al. (2002) · Research in Veterinary Science · doi:10.1053/rvsc.2001.0542 · Cited by 46
Presence, Actions, and Regulation of Myostatin in Rat Uterus and Myometrial Cells
Ciarmela, P., Wiater, E., Smith, S. M., & Vale, W. (2008) · Endocrinology · doi:10.1210/en.2008-0880 · Cited by 46
Antiprogestins as a model for progesterone withdrawal
Critchley, H., KELLY, R. W., Brenner, R., & Baird, D. T. (2003) · Steroids · doi:10.1016/j.steroids.2003.07.001 · Cited by 46
Clarke, C. L., Graham, J. D., Roman, S. D., & Sutherland, R. L. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55158-9 · Cited by 45
Self-citationLeslie, K. K., Kumar, N. S., Richer, J. K., et al. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48520.x · Cited by 46
Estrogen and interrupted progestin: A new concept for menopausal hormone replacement therapy
Casper, R. F., & Chapdelaine, A. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(93)90367-r · Cited by 46
Amicis, F. D., Zupo, S., Panno, M., Malivindi, R., Giordano, F., Barone, I., Mauro, L., Fuqua, S. A. W., & Andò, S. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0267 · Cited by 45
“enced by them and their receptors (1, 2).”
BackgroundGenome-wide association study of endometrial cancer in E2C2
Chenevix‐Trench, G., Vivo, I. D., Prescott, J., Setiawan, V. W., Olson, S. H., Wentzensen, N., Attia, J., Black, A., Brinton, L. A., Chen, C., et al. (2013) · Human Genetics · doi:10.1007/s00439-013-1369-1 · Cited by 46
“Progesterone counteracts the growthstimulatory effects of estrogen by inducing glandular and stromal differentiation (Clarke and Sutherland 1990; Ace and Okulicz 1995) and endometrial hyperplasia can be reversed by progestin therapy (Ehrlich et al. 1981).”
BackgroundSalazar, M. G. S., Lerma-Ortiz, A., Hooks, G. M., Ashley, A. K., & Ashley, R. L. (2016) · Gene · doi:10.1016/j.gene.2016.06.044 · Cited by 45
“In vitro experiments investigating the role of P4 regulating breast epithelial cell proliferation have produced inconsistent results, as reviewed by Clarke and Sutherland (Clarke and Sutherland, 1990).”
ResultProgestin inhibition of cell death in human breast cancer cell lines
Moore, M. R., Spence, J. B., Kiningham, K. K., et al. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.09.008 · Cited by 45
Neuroendocrine effects of different estradiol-progestin regimens in postmenopausal women
Stomati, M., Bersi, C., Rubino, S., Palumbo, M. A., Comitini, G., Genazzani, A. D., Santre, M., Petraglia, F., & Genazzani, A. R. (1997) · Maturitas · doi:10.1016/s0378-5122(97)00073-x · Cited by 44
“In vitro and in vivo studies have shown different actions of progestins on human tissues mediated by specific receptors [4–6].”
BackgroundGenomic and non-genomic actions of progestogens in the breast
Mueck, A. O., Ruan, X., Seeger, H., Fehm, T. N., & Neubauer, H. J. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.08.011 · Cited by 44
Velarde, M. C., Geng, Y., Eason, R. R., et al. (2005) · Biology of Reproduction · doi:10.1095/biolreprod.105.041855 · Cited by 44
“These results suggest the existence of a regulatory loop involving PGR, ESR1, and BTEB1 and highlight the importance of additional studies to carefully investigate this linkage, given its implication in the control of physiological and pathophysiological states regulated by P/PGR in numerous P-target tissues [7, 37].”
Utsunomiya, H., Suzuki, T., Ito, K., Moriya, T., Konno, R., Sato, S., Yaegashi, N., Okamura, K., & Sasano, H. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01766.x · Cited by 44
“Progesterone has been demonstrated to exert antioestrogenic effects upon oestrogenic stimuli in the human endometrium, which may also indicate the possibility for progesterone therapy in endometrial proliferative disorders (Clarke & Sutherland, 1990; Delingdisch, 1993; Ace & Okulicz, 1995).”
BackgroundEstrogen and Testosterone Attenuate Extracellular Matrix Loss in Collagen-Induced Arthritis in Rats
Ganesan, K., Tiwari, M., Balachandran, C., Manohar, B. M., & Puvanakrishnan, R. (2008) · Calcified Tissue International · doi:10.1007/s00223-008-9183-9 · Cited by 44
“that progesterone antagonized estrogen’s effects in the uterus by downregulation of cytoplasmic and nuclear estrogen receptor concentrations [44].”
BackgroundA complex role for the progesterone receptor in the response to vascular injury
Karas, R. H., van Eickels, M., Lydon, J. P., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11374 · Cited by 44
Gill, P. G., Gebski, V., Snyder, R. D., Burns, I., Levi, J. A., Byrne, M., & Coates, A. S. (1993) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058658 · Cited by 44
Ishida, M., Choi, J., Hirabayashi, K., Matsuwaki, T., Suzuki, M., Yamanouchi, K., Horai, R., Sudo, K., Iwakura, Y., & Nishihara, M. (2007) · Journal of Reproduction and Development · doi:10.1262/jrd.18125 · Cited by 43
“the placenta, pregnant uterus, and fetal tissue may be involved in protecting developing fetuses from progesterone, since high levels of progesterone exert cytotoxic effects [18].”
BackgroundDominant Expression of Progesterone Receptor Form B mRNA in Ovarian Endometriosis
Misao, R., Iwagaki, S., Fujimoto, J., Sun, W.-S., & Tamaya, T. (1999) · Hormone Research in Paediatrics · doi:10.1159/000023429 · Cited by 43
Molecular tools to reestablish progestin control of endometrial cancer cell proliferation
Dai, D. D., Kumar, N. S., Wolf, D. M., & Leslie, K. K. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.113844 · Cited by 41
Alkhalaf, M., & El‐Mowafy, A. M. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1790055 · Cited by 43
“The steroid hormone progesterone is an important growth regulator of normal and malignant breast epithelial cells, and is used to treat hormone-dependent breast tumors (Clarke & Sutherland 1990, Santen et al. 1990, Pasqualini et al. 1998, Sutherland et al. 1998).”
BackgroundFujimoto, J., Ichigo, S., Hirose, R., et al. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00057-5 · Cited by 43
Hormone replacement therapy and risk of breast cancer: the role of progestins
Stahlberg, C. I., Pedersen, A. T., Lynge, E., et al. (2003) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2003.00055.x · Cited by 43
Progestins and breast cancer: An epidemiologic review
Staffa, J., Newschaffer, C. J., Jones, J., et al. (1992) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(92)90688-f · Cited by 43
Neubauer, N. L., Ward, E. C., Patel, P., et al. (2011) · Hormones and Cancer · doi:10.1007/s12672-011-0065-7 · Cited by 42
“In the endometrium, progesterone antagonizes estrogen-mediated cell proliferation and promotes differentiation [1].”
Kararigas, G., Becher, E., Mahmoodzadeh, S., Knosalla, C., Hetzer, R., & Regitz‐Zagrosek, V. (2010) · Biology of Sex Differences · doi:10.1186/2042-6410-1-2 · Cited by 41
“Both progesterone and its receptor are necessary for successful pregnancy and birth [22-24].”
BackgroundLeeuwen, I. S. L., van Garderen, E., Rutteman, G. R., et al. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00173-4 · Cited by 42
SAKAGUCHI, H., Fujimoto, J., Hong, B. L., et al. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.01.042 · Cited by 42
“Progesterone is antagonistic to estrogenmediated cell proliferation and the principal hormone that promotes differentiation [2].”
BackgroundProgesterone and reproduction in marsupials: A review
Bradshaw, F. J., & Bradshaw, D. (2010) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2010.07.015 · Cited by 40
Lundin, E., Wirgin, I. I., Lukanova, A., et al. (2012) · Cancer Epidemiology · doi:10.1016/j.canep.2012.04.006 · Cited by 41
“It is well established that progesterone inhibits endometrial cell proliferation induced by estrogens through binding to the progesterone receptor [41].”
BackgroundLou, Y., Murtola, T. J., & Tuohimaa, P. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.01.024 · Cited by 41
Tissue- and hormone- dependent progesterone receptor distribution in the rat uterus
Sahlin, L., Masironi, B., Åkerberg, S., & Eriksson, H. (2006) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-4-47 · Cited by 41
Wiehle, R. D., Christov, K. T., & Mehta, R. G. (2007) · Oncology Reports · doi:10.3892/or.18.1.167 · Cited by 40
“Unlike its role in the uterus as a differentiation agent that opposes the proliferative actions of ER, progesterone is mitogenic in the breast (1). highest mitotic activity in breast tissue is found in the luteal phase (2,3).”
Vanzulli, S. I. (2002) · Carcinogenesis · doi:10.1093/carcin/23.5.749 · Cited by 40
White, M. M., Sheffer, I., Teeter, J. N., & Apostolakis, E. M. (2007) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.02058 · Cited by 40
“The ovarian steroid hormone progesterone (Prog) is important for female reproductive functions, including ovulation, uterine and mammary gland development, maintenance of pregnancy, and sexual behavior (Clarke & Sutherland 1990, Lydon et al. 1995).”
Dran, G., Lüthy, I. A., Molinolo, A., et al. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00668207 · Cited by 40
“As already mentioned, progestin-stimulatory effects have also been repor ted for MCF-7 and T-47D cells [2].”
BackgroundInfluential17β-Oestradiol stimulates capacitative Ca2+ entry in human endometrial cells
Perret, S., Dockery, P., & Harvey, B. J. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00464-6 · Cited by 40
Pasanen, S., Ylikomi, T. J., Syvälä, H., et al. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)00192-5 · Cited by 40
Expression of Progesterone Receptor Form A and B mRNAs in Uterine Leiomyoma
Fujimoto, J., Hirose, R., Ichigo, S., Sakaguchi, H., Li, Y., & Tamaya, T. (1998) · Tumor Biology · doi:10.1159/000029983 · Cited by 39
Uchikawa, M., Kawamura, M., Yamauchi, N., & Hattori, M. (2010) · Chronobiology International · doi:10.3109/07420528.2010.522289 · Cited by 38
Honoré, L. H., HANSON, J., & Andrew, S. E. (2006) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2006.00535.x · Cited by 39
Witkiewicz, A. K., McConnell, T. G., Potoczek, M., et al. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.06.012 · Cited by 39
“Progestin suppression of complex atypical hyperplasia (CAH) and well-differentiated adenocarcinoma (WDC) is thought to be due to down-regulation of estrogen receptors [1].”
BackgroundWiebe, J. P., Lewis, M. J., Cialacu, V., Pawlak, K. J., & Zhang, G. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.12.003 · Cited by 39
Sutherland, R. L., Lee, C. S. L., Feldman, R. S., et al. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90357-o · Cited by 39
Self-citationDifferential regulation of c-myc by progestins and antiestrogens in T-47D human breast cancer cells
Wong, M. S. J., & Murphy, L. C. (1991) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(91)90010-3 · Cited by 39
Yoo, J., Shin, H., Kim, T. H., Choi, W.-S., Ferguson, S. D., Fazleabas, A. T., Young, S. L., Lessey, B. A., Ha, U., & Jeong, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100481 · Cited by 38
“P4 achieves this inhibition by coordinating stromal-epithelial cross-talk [37,65,66] but the precise mechanisms is still unclear.”
BackgroundMcGowan, E. M., Saad, S., Bendall, L. J., et al. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000014041.58977.80 · Cited by 38
“Progesterone is known to inhibit cell proliferation [15] and, in cells transfected with PR, causes increased stress fibres and focal contacts [16] and increased cell adhesion to extracellular matrix.”
Self-citationClassen-Linke, I. (1998) · Human Reproduction Update · doi:10.1093/humupd/4.5.539 · Cited by 38
“PR increase in concentration in response to synthesis invoked by oestrogens, and this increase is preceded by an oestrogen-mediated increase in PR mRNA levels (Clarke and Sutherland, 1990; Aronica and Katzenellenbogen, 1991).”
BackgroundHild-Petito, S. A., Verhage, H. G., & Fazleabas, A. T. (1994) · Biology of Reproduction · doi:10.1095/biolreprod50.4.791 · Cited by 38
Dorfman, V. B., Saucedo, L., Giorgio, N. P. D., et al. (2013) · Biology of Reproduction · doi:10.1095/biolreprod.113.107995 · Cited by 37
Y It Matters—Sex Differences in Fetal Lung Development
Laube, M., & Thome, U. H. (2022) · Biomolecules · doi:10.3390/biom12030437 · Cited by 37
“PR activation generally promotes differentiation and inhibits cellular proliferation in contrast to estrogenic effects [130].”
BackgroundCurcumin inhibits MPA-induced secretion of VEGF from T47-D human breast cancer cells
Carroll, C. E., Ellersieck, M. R., & Hyder, S. M. (2008) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31814fae5d · Cited by 37
Bosschere, H. D., Ducatelle, R., Tshamala, M., et al. (2002) · Theriogenology · doi:10.1016/s0093-691x(02)00951-2 · Cited by 37
McGowan, E. M., Russell, A. J., Boonyaratanakornkit, V., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1255 · Cited by 37
“target tissues, including the control of cell proliferation in both the breast and uterus (7), with evidence that progestins can enhance breast cancer risk (8, 9).”
InfluentialSelf-citationVelarde, M. C., Iruthayanathan, M., Eason, R. R., et al. (2005) · Endocrinology · doi:10.1210/en.2005-1419 · Cited by 37
Misao, R., Nakanishi, Y., Iwagaki, S., et al. (1998) · Molecular Human Reproduction · doi:10.1093/molehr/4.11.1045 · Cited by 37
Hormone-replacement therapy and breast cancer
Marsden, J. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00732-5 · Cited by 38
Mammographic and ultrasonographic study of changes in the breast related to HRT
Özdemir, A., Konuş, Ö. L., Nas, T., et al. (1999) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(99)00102-2 · Cited by 37
A Risk-Benefit Appraisal of Transdermal Estradiol Therapy
Cheang, A., Sitruk-Ware, R. L., & Utian, W. H. (1993) · Drug Safety · doi:10.2165/00002018-199309050-00005 · Cited by 37
Progesterone stimulates pancreatic cell proliferation in vivo
Nieuwenhuizen, A. G., Schuiling, G., Liem, S., Moes, H., Koiter, T., & Uilenbroek, J. T. J. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1400256 · Cited by 36
“Perhaps the stimulatory effect of progesterone treatment on cell proliferation within the pancreas should be seen in the light of earlier observations that progesterone is able to stimulate cell proliferation in many other tissues, such as uterus, oviduct and mammary gland ( 29 ).”
BackgroundDNA Methylation Profiles of Female Steroid Hormone-Driven Human Malignancies
Campan, M., Weisenberger, D. J., & Laird, P. W. (2006) · Springer eBooks · doi:10.1007/3-540-31181-5_8 · Cited by 37
Progesterone signaling in breast and endometrium
Ballaré, C., Vallejo, G., Vicent, G. P., Saragüeta, P., & Beato, M. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.09.030 · Cited by 36
“Progesterone is an essential stimulus in the uterus, needed or in vivo proliferation of stromal cells [8,30].”
Weiler, P. J., & Wiebe, J. P. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2847 · Cited by 36
Gene Expression Profiling of the Effects of Castration and Estrogen Treatment in the Rat Uterus
Wu, X. (2003) · Biology of Reproduction · doi:10.1095/biolreprod.103.015420 · Cited by 36
“The development and function of female reproductive tissues are regulated by the actions of two major sex steroid hormones, estrogen and progesterone [1].”
BackgroundProgestins and breast cancer: an epidemiologic review
Wallach, E. E., Staffa, J. A., Newschaffer, C. J., et al. (1992) · Fertility and Sterility · doi:10.1016/s0015-0282(16)54888-2 · Cited by 36
Interplay of nuclear receptors (ER, PR, and GR) and their steroid hormones in MCF-7 cells
Hegde, S. M., Kumar, M. N., Kavya, K., Kumar, K. M. K., Nagesh, R., Patil, R. H., Babu, R. L., Ramesh, G. T., & Sharma, S. C. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2810-2 · Cited by 37
“Like ER and GR, PR isoforms also function as ligand-dependent transcription factors [5].”
Metadata
- Authors
- CLARKE, C. L., & SUTHERLAND, R. L.
- Affiliations
- Garvan Institute of Medical Research (AU)
- Corresponding author
- SUTHERLAND, ROBERT L.
- ORCID
- CLARKE, CHRISTINE L.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 1990-05
- Volume
- 11
- Issue
- 2
- Pages
- 266-301
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2056357500
- Cited by
- 650
- References
- 0
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 8 · 2023: 4 · 2022: 9 · 2021: 7 · 2020: 5 · 2019: 7 · 2018: 6 · 2017: 10 · 2016: 12 · 2015: 18 · 2014: 12 · 2013: 15 · 2012: 21
- FWCI
- 10.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- progestins, cell proliferation, steroid hormones, growth factors, estrogen, breast cancer cells, immature uterus, autocrine and paracrine signaling, cell cycle regulation
- MeSH terms
- Animals, Haplorhini, Cell Division, Chickens, Humans, Progestins, Rabbits, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review